Clinical Trial Update: A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous carboplatin in combination with mirvetuximab soravtansine for newly diagnosed FRα-expressing advanced serous epith…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Mirvetuximab soravtansine (mirvetuximab soravtansine)

Snippet

Sponsor: AbbVie | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: RECRUITING